Your browser doesn't support javascript.
loading
Minimal Change Disease Associated With Durvalumab.
Toda, Masataro G; Fujii, Kentaro; Kato, Ai; Yoshifuji, Ayumi; Komatsu, Motoaki; Amino, Yoshiaki; Kitazono, Satoru; Hashiguchi, Akinori; Ryuzaki, Munekazu.
Affiliation
  • Toda MG; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Fujii K; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Kato A; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Yoshifuji A; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Komatsu M; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
  • Amino Y; Department of Respiratory Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kitazono S; Department of Respiratory Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Hashiguchi A; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
  • Ryuzaki M; Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Kidney Int Rep ; 6(10): 2733-2734, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34622115
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Kidney Int Rep Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Kidney Int Rep Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United States